Roswall, Pernilla
Bocci, Matteo
Bartoschek, Michael
Li, Hong
Kristiansen, Glen
Jansson, Sara
Lehn, Sophie
Sjölund, Jonas
Reid, Steven
Larsson, Christer
Eriksson, Pontus
Anderberg, Charlotte
Cortez, Eliane
Saal, Lao H http://orcid.org/0000-0002-0815-1896
Orsmark-Pietras, Christina
Cordero, Eugenia
Haller, Bengt Kristian
Häkkinen, Jari http://orcid.org/0000-0002-8466-9179
Burvenich, Ingrid J G
Lim, Elgene
Orimo, Akira
Höglund, Mattias
Rydén, Lisa
Moch, Holger
Scott, Andrew M
Eriksson, Ulf http://orcid.org/0000-0002-4439-3980
Pietras, Kristian
Article History
Received: 11 July 2016
Accepted: 12 January 2018
First Online: 12 March 2018
Competing interests
: K.P., U.E. and P.R. are named inventors on Patent Cooperation Treaty (PCT) application no. PCT/EP2016/077295, which is related to the findings of the current study. K.P., U.E. and A.M.S. are shareholders of Paracrine Therapeutics, which develops inhibitory agents to PDGF-CC.